arepanrix
Vaccineexperimental
Clinical trial activity
7 trials · 17 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
6
Earliest trial started Nov 1, 2009 (NCT01000584)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- arepanrix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07240558 | Phase 3 | Nov 3, 2025 | Laval University, University of Toronto |
| NCT07275060 | Phase 4 | Oct 14, 2025 | Canadian Center for Vaccinology, Canadian Immunization Research Network, Dalhousie University, Government of Canada, Laval University, McGill University, University of British Columbia |
| NCT01114620 | Phase 4 | May 1, 2010 | GlaxoSmithKline |
| NCT01002040 | Phase 4 | Feb 1, 2010 | Canadian Institutes of Health Research (CIHR), Dalhousie University, GlaxoSmithKline, McGill University, University of British Columbia, University of Ottawa, University of Toronto |
| NCT01000584 | Phase 4 | Nov 1, 2009 | Canadian Institutes of Health Research (CIHR), Institut national de sante publique du Quebec, Kingston, Frontenac, Lanark Health Unit, McMaster University, University of British Columbia, University of Toronto |
| NCT01001026 | Phase 4 | Nov 1, 2009 | Canadian Institutes of Health Research (CIHR), PHAC/CIHR Influenza Research Network, University of British Columbia, University of Calgary, University of Manitoba |
| NCT01000831 | Phase 4 | Nov 1, 2009 | Canadian Institutes of Health Research (CIHR), Dalhousie University, McGill University, PHAC/CIHR Influenza Research Network, University of British Columbia, University of Calgary |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (17)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of British Columbia | Academic/Hospital | 5 | 4 | 1 | 2009 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 4 | 0 | 1 | 2009 |
| Dalhousie University | Academic/Hospital | 3 | 0 | 1 | 2009 |
| McGill University | Academic/Hospital | 3 | 0 | 1 | 2009 |
| University of Toronto | Academic/Hospital | 3 | 1 | 2 | 2009 |
| GlaxoSmithKline | For profit | 2 | 1 | 1 | 2010 |
| Laval University | Academic/Hospital | 2 | 0 | 2 | 2025 |
| PHAC/CIHR Influenza Research Network | Academic/Hospital | 2 | 0 | 1 | 2009 |
| University of Calgary | Academic/Hospital | 2 | 0 | 1 | 2009 |
| Canadian Center for Vaccinology | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Canadian Immunization Research Network | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Government of Canada | Government | 1 | 0 | 1 | 2025 |
| Institut national de sante publique du Quebec | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Kingston, Frontenac, Lanark Health Unit | Academic/Hospital | 1 | 0 | 1 | 2009 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Manitoba | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Ottawa | Academic/Hospital | 1 | 0 | 1 | 2010 |
17 organizations
Page 1 / 1